Pyxis Oncology issues 49,310,352 common stock warrants in $110 million offering

Bitget2026/09/30 05:11

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pyxis Oncology priced a public offering with 1,883,121 pre-funded warrants issued alongside common warrants for 49,310,352 shares.
Common warrants carry a $3.50 exercise price. They become exercisable only after stockholder approval of an authorized-share increase.
Common warrants expire at the earlier of five years from the charter amendment’s effective date or 30 days after overall survival data disclosure.
Full exercise of the common warrants and pre-funded warrants would raise an additional USD 172.6 million in gross proceeds.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609300111PRIMZONEFULLFEED9836674) on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Pyxis Oncology issues 49,310,352 common stock warrants in $110 million offering

You may also like

Crypto prices